The Business Case for Quality Mental Health Services: Why Employers Should Care About the Mental Health and Well-Being of Their Employees
- 1 April 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 44 (4) , 320-330
- https://doi.org/10.1097/00043764-200204000-00012
Abstract
Employers are very concerned about rising mental health care costs. They want to know whether their health care spending is improving the health of workers, and whether there is a productivity payback from providing good mental health care. This article addresses the subject of employee depression and its impact on business. The literature suggests that depressed individuals exert a significant cost burden for employers. Evidence is mounting that worker depression may have its greatest impact on productivity losses, including increased absenteeism and short-term disability, higher turnover, and suboptimal performance at work. Although there is no conclusive evidence yet that physical health care costs decrease when depression is effectively treated, there is growing evidence that productivity improvements occur as a consequence of effective treatment, and those improvements may offset the cost of the treatment.Keywords
This publication has 42 references indexed in Scilit:
- The Effects of Chronic Medical Conditions on Work Loss and Work CutbackJournal of Occupational and Environmental Medicine, 2001
- Disease Management as a Part of Total Health and Productivity ManagementDisease Management and Health Outcomes, 2000
- Health and Disability Costs of Depressive Illness in a Major U.S. CorporationAmerican Journal of Psychiatry, 2000
- Spending On Mental Health And Substance Abuse Treatment, 1987–1997Health Affairs, 2000
- The Relationship Between Modifiable Health Risks and Health Care ExpendituresJournal of Occupational and Environmental Medicine, 1998
- What Does Treatment Of Depression Really Cost?Health Affairs, 1998
- Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illnessBiological Psychiatry, 1997
- Depression and 18-Month Prognosis After Myocardial InfarctionCirculation, 1995
- Adequacy and Duration of Antidepressant Treatment in Primary CareMedical Care, 1992
- Clinical depression: Comparative efficacy of outpatient treatments.Journal of Consulting and Clinical Psychology, 1979